|
Delaware
(State
or Other Jurisdiction of Incorporation or Organization)
|
000-24487
(Commission
File Number)
|
77-0322161
(IRS
Employer Identification No.)
|
|
Exhibit
No.
|
Description
|
|||
|
99
|
.01
|
Press
Release, dated August 1, 2007, entitled "MIPS Technologies
Reports Fourth Quarter and Fiscal Year 2007 Financial
Results."
|
||
|
Media
Contact:
Jodi
Guilbault
MIPS
Technologies, Inc.
+1
650 567-5035
jodi@mips.com
|
Investor
Contact:
Mark
Tyndall
MIPS
Technologies, Inc.
+1
650 567-5100
ir@mips.com
|
|
·
|
Infineon
Licenses MIPS Next-Generation MIPS32® 74K™ Core: Top Semiconductor Company
Becomes First Customer After GA to Leverage Embedded Industry's
Fastest
Processor
|
|
·
|
Teradici
Licenses MIPS Technologies' Most Popular Embedded Processor for
Innovative
TERA Chipset in Datacenter-Based
Computing
|
|
·
|
MIPS
Technologies Files Annual Report, Quarterly Reports and Proxy
Statement
|
|
·
|
TrendChip
Technologies Licenses MIPS32® 24KE™ and MIPS32 34K™ Cores for Cutting-Edge
Broadband Access Solutions
|
|
·
|
EDA
Leaders Team with MIPS Technologies to Support New High-performance
MIPS32® 74K™ Core Family
|
|
·
|
Kolorific
Licenses MIPS32® 24KEc™ Core for Next-Generation iDTV
Applications
|
|
·
|
MIPS
Technologies Unveils Industry’s First Fully Synthesizable Processors to
Surpass 1 GHz; Broadcom Takes Early
License
|
|
·
|
FS2®
Introduces SYSTEM NAVIGATOR™ Tools for MIPS32® 74K™ Core
Debug
|
|
·
|
Entropic
Marks Milestone with Shipment of Five Millionth MIPS-Based™ Coax
Network Chipset
|
|
·
|
MIPS64®
Architecture Licensed by NEC Electronics for Next-Generation VR
Series™
Processor Core
|
|
·
|
MIPS
Technologies and Trident Microsystems Complete Licensing Agreement
for
MIPS32® 24KEc™ Pro Core
|
|
·
|
Next-Generation
MIPS-Based™ Designs Spotlight Innovation at Embedded Systems
Conference
|
|
June
30,
2007
|
June
30,
2006
|
|||||||
|
Assets
|
||||||||
|
Current
assets:
|
||||||||
|
Cash
and cash equivalents
|
$ |
119,039
|
$ |
101,481
|
||||
|
Marketable
investments
|
25,845
|
19,725
|
||||||
|
Accounts
receivable,
net
|
5,212
|
4,631
|
||||||
|
Prepaid
expenses and other
current assets
|
2,472
|
3,157
|
||||||
|
Total
current
assets
|
152,568
|
128,994
|
||||||
|
Equipment
and furniture, net
|
5,781
|
2,718
|
||||||
|
Other
assets
|
16,513
|
16,227
|
||||||
| $ |
174,862
|
$ |
147,939
|
|||||
|
Liabilities
and Stockholders’ Equity
|
||||||||
|
Current
liabilities:
|
||||||||
|
Accounts
payable
|
$ |
503
|
$ |
1,313
|
||||
|
Accrued
liabilities
|
16,118
|
8,287
|
||||||
|
Deferred
revenue
|
2,633
|
2,143
|
||||||
|
Total
current
liabilities
|
19,254
|
11,743
|
||||||
|
Long-term
liabilities
|
5,726
|
2,966
|
||||||
|
Stockholders’
equity
|
149,882
|
133,230
|
||||||
| $ |
174,862
|
$ |
147,939
|
|||||
|
Three
Months Ended
June
30,
|
Twelve
Months Ended
June
30,
|
|||||||||||||||
|
2007
|
2006
|
2007
|
2006
|
|||||||||||||
|
Revenue:
|
||||||||||||||||
|
Royalties
|
$ |
11,294
|
$ |
10,357
|
$ |
44,422
|
$ |
36,675
|
||||||||
|
Contract
Revenue
|
12,385
|
7,882
|
38,888
|
27,379
|
||||||||||||
|
Total
revenue
|
23,679
|
18,239
|
83,310
|
64,054
|
||||||||||||
|
Costs
and expenses:
|
||||||||||||||||
|
Research
and
development
|
9,231
|
7,503
|
34,513
|
28,168
|
||||||||||||
|
Sales
and
marketing
|
6,994
|
4,868
|
22,473
|
18,637
|
||||||||||||
|
General
and
administrative
|
7,093
|
2,967
|
20,960
|
12,229
|
||||||||||||
|
Acquired
in-process research and development
|
-
|
-
|
-
|
570
|
||||||||||||
|
Total
costs and
expenses
|
23,318
|
15,338
|
77,946
|
59,604
|
||||||||||||
|
Operating
income
|
361
|
2,901
|
5,364
|
4,450
|
||||||||||||
|
Other
income, net
|
1,653
|
1,396
|
6,470
|
4,373
|
||||||||||||
|
Income
before income taxes
|
2,014
|
4,297
|
11,834
|
8,823
|
||||||||||||
|
Provision
(benefit) for income taxes
|
(321 | ) | (3,178 | ) |
3,351
|
(2,198 | ) | |||||||||
|
Net
income
|
$ |
2,335
|
$ |
7,475
|
$ |
8,483
|
$ |
11,021
|
||||||||
|
Net
income per basic share
|
$ |
0.05
|
$ |
0.17
|
$ |
0.19
|
$ |
0.26
|
||||||||
|
Net
income per diluted share
|
$ |
0.05
|
$ |
0.17
|
$ |
0.18
|
$ |
0.25
|
||||||||
|
Common
shares outstanding-basic
|
43,535
|
43,379
|
43,516
|
42,894
|
||||||||||||
|
Common
shares outstanding-diluted
|
46,374
|
44,987
|
45,891
|
44,611
|
||||||||||||
|
Three
Months Ended
June
30, 2007
|
Three
Months Ended
March
31, 2007
|
Three
Months Ended
June
30, 2006
|
||||||||||||
|
GAAP
net income
|
$ |
2,335
|
$ |
1,237
|
$ |
7,475
|
||||||||
|
Net
income per basic share
|
$ |
0.05
|
$ |
0.03
|
$ |
0.17
|
||||||||
|
Net
income per diluted share
|
$ |
0.05
|
$ |
0.03
|
$ |
0.17
|
||||||||
|
(a)
|
Equity-based
compensation expense under SFAS 123R (see note below)
|
$ |
1,619
|
$ |
2,251
|
$ |
1,669
|
|||||||
|
Non-GAAP
net income
|
$ |
3,954
|
$ |
3,488
|
$ |
9,144
|
||||||||
|
Non-GAAP
net income per basic share
|
$ |
0.09
|
$ |
0.08
|
$ |
0.21
|
||||||||
|
Non-GAAP
net income per diluted share
|
$ |
0.09
|
$ |
0.08
|
$ |
0.20
|
||||||||
|
Common
shares outstanding – basic
|
43,535
|
43,535
|
43,379
|
|||||||||||
|
Common
shares outstanding - diluted
|
46,374
|
46,384
|
44,987
|
|||||||||||
|
(a)
|
Non-cash
equity-based compensation expense related to the Company’s adoption of
SFAS No. 123 revised (123R) beginning July 1, 2005. For the fourth
fiscal
quarter ending June 30, 2007 of $1.6 million, allocated as
follows: $539,000 to research and development, $508,000 to
sales and marketing and $572,000 to general and administrative.
For the
third fiscal quarter ending March 31, 2007 of $2.3 million, allocated
as
follows: $871,000 to research and development, $721,000 to
sales and marketing and $660,000 to general and
administrative. For the fourth quarter of fiscal 2006 ending
March 31, 2006 of $1.7 million, allocated as follows: $639,000
to research and development, $468,000 to sales and marketing and
$562,000
to general and administrative. Management believes that it is
useful to investors to understand how the expenses associated with
the
adoption of SFAS 123R are reflected in net
income.
|
|
Twelve
Months Ended
June
30, 2007
|
Twelve
Months Ended
June
30, 2006
|
|||||||||
|
GAAP
net income
|
$ |
8,483
|
$ |
11,021
|
||||||
|
Net
income per basic share
|
$ |
0.19
|
$ |
0.26
|
||||||
|
Net
income per diluted share
|
$ |
0.18
|
$ |
0.25
|
||||||
|
(a)
|
Equity-based
compensation expense under SFAS 123R (see note below)
|
$ |
7,701
|
$ |
8,279
|
|||||
|
(b)
|
Acquired
in-process research and development (see note below)
|
-
|
$ |
570
|
||||||
|
Non-GAAP
net income
|
$ |
16,184
|
$ |
19,870
|
||||||
|
Non-GAAP
net income per basic share
|
$ |
0.37
|
$ |
0.46
|
||||||
|
Non-GAAP
net income per diluted share
|
$ |
0.35
|
$ |
0.44
|
||||||
|
Common
shares outstanding – basic
|
43,516
|
42,894
|
||||||||
|
Common
shares outstanding - diluted
|
45,891
|
44,611
|
||||||||
|
(a)
|
Non-cash
equity-based compensation expense of $7.7 million in fiscal 2007
related
to the Company’s adoption of SFAS No. 123 revised (123R) beginning in the
first quarter of fiscal 2006, allocated as follows: $2.9
million to research and development, $2.3 million to sales and
marketing
and $2.5 million to general and administrative. For fiscal 2006
ending June 30, 2006 of $8.3 million, allocated as
follows: $4.0 million to research and development, $1.9 million
to sales and marketing and $2.4 million to general and
administrative. Management believes that it is
useful to investors to understand how the expenses associated with
the
adoption of SFAS 123R are reflected in net
income.
|
|
(b)
|
The
charge of $570,000 for acquired in-process research and development
expense related to the acquisition of First Silicon Solutions (FS2)
completed in September 2005. Management believes that excluding
this charge facilitates comparisons to MIPS’ core operating results during
periods when there were no
acquisitions.
|